These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37443366)

  • 1. Profound structural conservation of chemically cross-linked HIV-1 envelope glycoprotein experimental vaccine antigens.
    Martin GM; Russell RA; Mundsperger P; Harris S; Jovanoska L; Trajano LF; Schiffner T; Fabian K; Tolazzi M; Scarlatti G; McFarlane L; Cheeseman H; Aldon Y; Schermer EE; Breemen M; Sliepen K; Katinger D; Kunert R; Sanders RW; Shattock R; Ward AB; Sattentau QJ
    NPJ Vaccines; 2023 Jul; 8(1):101. PubMed ID: 37443366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical Cross-Linking Stabilizes Native-Like HIV-1 Envelope Glycoprotein Trimer Antigens.
    Schiffner T; de Val N; Russell RA; de Taeye SW; de la Peña AT; Ozorowski G; Kim HJ; Nieusma T; Brod F; Cupo A; Sanders RW; Moore JP; Ward AB; Sattentau QJ
    J Virol; 2016 Jan; 90(2):813-28. PubMed ID: 26512083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteins.
    Schiffner T; Pallesen J; Russell RA; Dodd J; de Val N; LaBranche CC; Montefiori D; Tomaras GD; Shen X; Harris SL; Moghaddam AE; Kalyuzhniy O; Sanders RW; McCoy LE; Moore JP; Ward AB; Sattentau QJ
    PLoS Pathog; 2018 May; 14(5):e1006986. PubMed ID: 29746590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenicity and Immunogenicity of HIV-1 Envelope Trimers Complexed to a Small-Molecule Viral Entry Inhibitor.
    Alam SM; Cronin K; Parks R; Anasti K; Ding H; Go EP; Desaire H; Eaton A; Montefiori D; Sodroski J; Kappes J; Haynes BF; Saunders KO
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32817216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene.
    Pugach P; Ozorowski G; Cupo A; Ringe R; Yasmeen A; de Val N; Derking R; Kim HJ; Korzun J; Golabek M; de Los Reyes K; Ketas TJ; Julien JP; Burton DR; Wilson IA; Sanders RW; Klasse PJ; Ward AB; Moore JP
    J Virol; 2015 Mar; 89(6):3380-95. PubMed ID: 25589637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity.
    Hu JK; Crampton JC; Cupo A; Ketas T; van Gils MJ; Sliepen K; de Taeye SW; Sok D; Ozorowski G; Deresa I; Stanfield R; Ward AB; Burton DR; Klasse PJ; Sanders RW; Moore JP; Crotty S
    J Virol; 2015 Oct; 89(20):10383-98. PubMed ID: 26246566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convergent HIV-1 Evolution upon Targeted Destabilization of the gp120-gp41 Interface.
    Torrents de la Peña A; Del Moral Sánchez I; Burger JA; Bontjer I; Isik G; Eggink D; van Gils MJ; Sanders RW
    J Virol; 2021 Nov; 95(24):e0053221. PubMed ID: 34586861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilized HIV-1 envelope glycoprotein trimers for vaccine use.
    Medina-Ramírez M; Sanders RW; Sattentau QJ
    Curr Opin HIV AIDS; 2017 May; 12(3):241-249. PubMed ID: 28422788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenic Display of Purified Chemically Cross-Linked HIV-1 Spikes.
    Leaman DP; Lee JH; Ward AB; Zwick MB
    J Virol; 2015 Jul; 89(13):6725-45. PubMed ID: 25878116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similarities and differences between native HIV-1 envelope glycoprotein trimers and stabilized soluble trimer mimetics.
    Torrents de la Peña A; Rantalainen K; Cottrell CA; Allen JD; van Gils MJ; Torres JL; Crispin M; Sanders RW; Ward AB
    PLoS Pathog; 2019 Jul; 15(7):e1007920. PubMed ID: 31306470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Antibody Responses to Conserved HIV-1 Neutralizing Epitopes in the Context of Multivalent Scaffolds and Native-Like gp140 Trimers.
    Morris CD; Azadnia P; de Val N; Vora N; Honda A; Giang E; Saye-Francisco K; Cheng Y; Lin X; Mann CJ; Tang J; Sok D; Burton DR; Law M; Ward AB; He L; Zhu J
    mBio; 2017 Feb; 8(1):. PubMed ID: 28246356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influences on the Design and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers.
    Ringe RP; Yasmeen A; Ozorowski G; Go EP; Pritchard LK; Guttman M; Ketas TA; Cottrell CA; Wilson IA; Sanders RW; Cupo A; Crispin M; Lee KK; Desaire H; Ward AB; Klasse PJ; Moore JP
    J Virol; 2015 Dec; 89(23):12189-210. PubMed ID: 26311893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Throughput Protein Engineering Improves the Antigenicity and Stability of Soluble HIV-1 Envelope Glycoprotein SOSIP Trimers.
    Sullivan JT; Sulli C; Nilo A; Yasmeen A; Ozorowski G; Sanders RW; Ward AB; Klasse PJ; Moore JP; Doranz BJ
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational Differences between Functional Human Immunodeficiency Virus Envelope Glycoprotein Trimers and Stabilized Soluble Trimers.
    Castillo-Menendez LR; Nguyen HT; Sodroski J
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Adjuvants on HIV-1 Envelope Glycoprotein SOSIP Trimers
    Ozorowski G; Cupo A; Golabek M; LoPiccolo M; Ketas TA; Cavallary M; Cottrell CA; Klasse PJ; Ward AB; Moore JP
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HIV-1 envelope glycoprotein structure: nailing down a moving target.
    Ward AB; Wilson IA
    Immunol Rev; 2017 Jan; 275(1):21-32. PubMed ID: 28133813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralizing Antibodies Induced by First-Generation gp41-Stabilized HIV-1 Envelope Trimers and Nanoparticles.
    Kumar S; Lin X; Ngo T; Shapero B; Sou C; Allen JD; Copps J; Zhang L; Ozorowski G; He L; Crispin M; Ward AB; Wilson IA; Zhu J
    mBio; 2021 Jun; 12(3):e0042921. PubMed ID: 34156262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan.
    Liang Y; Guttman M; Williams JA; Verkerke H; Alvarado D; Hu SL; Lee KK
    J Virol; 2016 Oct; 90(20):9224-36. PubMed ID: 27489265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and structure of two HIV-1 clade C SOSIP.664 trimers that increase the arsenal of native-like Env immunogens.
    Julien JP; Lee JH; Ozorowski G; Hua Y; Torrents de la Peña A; de Taeye SW; Nieusma T; Cupo A; Yasmeen A; Golabek M; Pugach P; Klasse PJ; Moore JP; Sanders RW; Ward AB; Wilson IA
    Proc Natl Acad Sci U S A; 2015 Sep; 112(38):11947-52. PubMed ID: 26372963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilizing the native trimer of HIV-1 Env by destabilizing the heterodimeric interface of the gp41 postfusion six-helix bundle.
    Kesavardhana S; Varadarajan R
    J Virol; 2014 Sep; 88(17):9590-604. PubMed ID: 24920800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.